FSL2 Post Approval Study for Pediatric and Young Adults Patients

RecruitingOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Diabete Mellitus
Interventions
DEVICE

FreeStyle Libre 2

The FreeStyle Libre 2 Flash Glucose Monitoring

Trial Locations (3)

64108

RECRUITING

The Children's Mercy Hospital, Kansas City

89113

RECRUITING

The DOCS, Las Vegas

06511

RECRUITING

Yale Pediatric Endocrinology Clinic, New Haven

Sponsors
All Listed Sponsors
lead

Abbott Diabetes Care

INDUSTRY

NCT04959552 - FSL2 Post Approval Study for Pediatric and Young Adults Patients | Biotech Hunter | Biotech Hunter